Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Abeona Therapeutics (ABEO) Assets Average (2016 - 2025)

Abeona Therapeutics (ABEO) has 15 years of Assets Average data on record, last reported at $238.7 million in Q3 2025.

  • For Q3 2025, Assets Average rose 87.49% year-over-year to $238.7 million; the TTM value through Sep 2025 reached $238.7 million, up 87.49%, while the annual FY2024 figure was $86.5 million, 34.88% up from the prior year.
  • Assets Average reached $238.7 million in Q3 2025 per ABEO's latest filing, up from $172.8 million in the prior quarter.
  • Across five years, Assets Average topped out at $238.7 million in Q3 2025 and bottomed at $41.7 million in Q3 2022.
  • Average Assets Average over 5 years is $99.2 million, with a median of $99.3 million recorded in 2021.
  • Peak YoY movement for Assets Average: tumbled 66.57% in 2022, then soared 112.81% in 2024.
  • A 5-year view of Assets Average shows it stood at $99.3 million in 2021, then crashed by 48.15% to $51.5 million in 2022, then rose by 26.33% to $65.0 million in 2023, then soared by 76.44% to $114.8 million in 2024, then surged by 107.97% to $238.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Assets Average were $238.7 million in Q3 2025, $172.8 million in Q2 2025, and $104.1 million in Q1 2025.